Using magnesium to protect the brain after cardiac arrest
Neuroprotection following cardiac arrest: A Randomized Control Trial of Magnesium
This study is looking at whether magnesium can help protect the brain and improve recovery for people who have survived a cardiac arrest, by reducing brain injury caused by a lack of blood flow.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10914294 on NIH RePORTER |
What this research studies
This research investigates the potential of magnesium as a neuroprotective agent for patients who have experienced cardiac arrest. It aims to understand how magnesium can help reduce brain injury caused by the lack of blood flow and subsequent inflammation when blood circulation is restored. The study will involve a randomized control trial to gather data on the safety and effectiveness of magnesium treatment in improving neurological outcomes for survivors of cardiac arrest. Patients will be monitored closely to assess the impact of magnesium on their recovery.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently experienced a cardiac arrest and are receiving post-resuscitation care.
Not a fit: Patients who have not experienced cardiac arrest or those with contraindications to magnesium treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better neurological recovery for patients who have suffered cardiac arrest.
How similar studies have performed: Previous small-scale studies have shown promising results for magnesium in improving outcomes after cardiac arrest, indicating potential for success in this larger trial.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Parnia, Sam — New York University School of Medicine
- Study coordinator: Parnia, Sam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.